biospecimen__admin__batch_number	399.48.0
biospecimen__admin__bcr	Nationwide Children's Hospital
biospecimen__admin__day_of_dcc_upload	1
biospecimen__admin__disease_code	LIHC
biospecimen__admin__file_uuid	2A273EB8-27D5-4DF5-A6BF-C9E656A6335F
biospecimen__admin__month_of_dcc_upload	7
biospecimen__admin__year_of_dcc_upload	2016
biospecimen__bio__bcr_analyte_barcode	TCGA-2Y-A9GW-01A-11R
biospecimen__bio__bcr_portion_barcode	TCGA-2Y-A9GW-01A-11
biospecimen__bio__bcr_sample_barcode	TCGA-2Y-A9GW-01A
biospecimen__bio__biospecimen_barcode_bottom	0164104720
biospecimen__bio__day_of_creation	14
biospecimen__bio__day_of_shipment	26
biospecimen__bio__days_to_index	0
biospecimen__bio__gel_image_file	https://sharedoc.nchri.org/tcga-bcr/default.aspx
biospecimen__bio__is_derived_from_ffpe	NO
biospecimen__bio__month_of_creation	02
biospecimen__bio__month_of_shipment	03
biospecimen__bio__pathology_report_file_name	TCGA-2Y-A9GW.5846FA3D-E3AD-4530-8A5F-5D90CD17F539.pdf
biospecimen__bio__plate_column	8
biospecimen__bio__plate_id	A38M
biospecimen__bio__plate_row	G
biospecimen__bio__quantity	3.40
biospecimen__bio__subportion_sequence	1
biospecimen__bio__vial_number	A
biospecimen__bio__volume	20.00
biospecimen__bio__year_of_creation	2014
biospecimen__bio__year_of_shipment	2014
biospecimen__shared__bcr_patient_barcode	TCGA-2Y-A9GW
biospecimen__shared__patient_id	A9GW
clinical__admin__day_of_dcc_upload	22
clinical__admin__file_uuid	8FC73A6F-3467-4B9D-A77A-5A367242CE87
clinical__admin__month_of_dcc_upload	12
clinical__admin__withdrawn	false
clinical__chol_lihc_shared__albumin_result_lower_limit	3.5
clinical__chol_lihc_shared__albumin_result_specified_value	4.5
clinical__chol_lihc_shared__albumin_result_upper_limit	5
clinical__chol_lihc_shared__bilirubin_lower_limit	0.2
clinical__chol_lihc_shared__bilirubin_upper_limit	0.6
clinical__chol_lihc_shared__creatinine_lower_level	0.8
clinical__chol_lihc_shared__creatinine_upper_limit	1.5
clinical__chol_lihc_shared__creatinine_value_in_mg_dl	1
clinical__chol_lihc_shared__fetoprotein_outcome_lower_limit	0
clinical__chol_lihc_shared__fetoprotein_outcome_upper_limit	6
clinical__chol_lihc_shared__fetoprotein_outcome_value	2
clinical__chol_lihc_shared__hist_hepato_carc_fact	Alcohol consumption
clinical__chol_lihc_shared__inter_norm_ratio_lower_limit	8.3
clinical__chol_lihc_shared__intern_norm_ratio_upper_limit	11.5
clinical__chol_lihc_shared__platelet_result_lower_limit	143
clinical__chol_lihc_shared__platelet_result_upper_limit	382
clinical__chol_lihc_shared__prothrombin_time_result_value	9.7
clinical__chol_lihc_shared__specimen_collection_method_name	Segmentectomy, Multiple
clinical__chol_lihc_shared__total_bilirubin_upper_limit	1.3
clinical__clin_shared__age_at_initial_pathologic_diagnosis	64
clinical__clin_shared__cancer_first_degree_relative	1
clinical__clin_shared__day_of_form_completion	3
clinical__clin_shared__days_to_initial_pathologic_diagnosis	0
clinical__clin_shared__informed_consent_verified	YES
clinical__clin_shared__month_of_form_completion	11
clinical__clin_shared__person_neoplasm_cancer_status	WITH TUMOR
clinical__clin_shared__platelet_result_count	175
clinical__clin_shared__post_op_ablation_embolization_tx	NO
clinical__clin_shared__postoperative_rx_tx	NO
clinical__clin_shared__radiation_therapy	NO
clinical__clin_shared__relative_family_cancer_history	YES
clinical__clin_shared__residual_tumor	R0
clinical__clin_shared__tissue_prospective_collection_indicator	NO
clinical__clin_shared__tissue_retrospective_collection_indicator	YES
clinical__clin_shared__tumor_tissue_site	Liver
clinical__clin_shared__year_of_form_completion	2014
clinical__clin_shared__year_of_initial_pathologic_diagnosis	2007
clinical__lihc__adjacent_hepatic_tissue_inflammation_extent_type	None
clinical__lihc_nte__new_tumor_event_ablation_embo_tx	No
clinical__lihc_nte__new_tumor_event_liver_transplant	No
clinical__nte__additional_pharmaceutical_therapy	NO
clinical__nte__additional_radiation_therapy	NO
clinical__nte__days_to_new_tumor_event_after_initial_treatment	1229
clinical__nte__new_neoplasm_event_occurrence_anatomic_site	Liver
clinical__nte__new_neoplasm_event_type	Locoregional Recurrence
clinical__nte__new_tumor_event_additional_surgery_procedure	NO
clinical__nte__new_tumor_event_after_initial_treatment	YES
clinical__shared__histological_type	Hepatocellular Carcinoma
clinical__shared__history_of_neoadjuvant_treatment	No
clinical__shared__neoplasm_histologic_grade	G2
clinical__shared__other_dx	No
clinical__shared_stage__pathologic_m	MX
clinical__shared_stage__pathologic_n	N0
clinical__shared_stage__pathologic_t	T1
clinical__shared_stage__system_version	6th
gdc__access	open
gdc__acl	open
gdc__aliquots__aliquot_id	764e0717-d590-4e52-96ca-96e5ba7673f7
gdc__aliquots__concentration	0.17
gdc__aliquots__source_center	23
gdc__aliquots__submitter_id	TCGA-2Y-A9GW-01A-11R-A38M-13
gdc__aliquots__updated_datetime	2018-09-06T14:13:07.098771-05:00
gdc__analysis__analysis_id	5e6e238a-3b96-4612-9564-7ee4977d9170
gdc__analysis__workflow_link	https://github.com/NCI-GDC/gdc-dnaseq-cwl/blob/gdc-active-submission/workflows/mirnaseq/runner.cwl
gdc__analysis__workflow_type	BCGSC miRNA Profiling
gdc__analytes__a260_a280_ratio	1.88
gdc__analytes__analyte_id	9fb4fb04-7e85-43f9-85c0-74484771fd0c
gdc__analytes__analyte_type	RNA
gdc__analytes__analyte_type_id	R
gdc__analytes__spectrophotometer_method	UV Spec
gdc__case_id	3e1920b3-3bd4-4506-a0cf-567257154bcf
gdc__center__center_id	6eba705a-0f00-5aa2-b1d0-04dbf62100cc
gdc__center__center_type	CGCC
gdc__center__code	13
gdc__center__name	Canada's Michael Smith Genome Sciences Centre
gdc__center__namespace	bcgsc.ca
gdc__center__short_name	BCGSC
gdc__created_datetime	2018-03-20T12:32:47.609868-05:00
gdc__data_category	Transcriptome Profiling
gdc__data_format	TXT
gdc__data_type	miRNA Expression Quantification
gdc__demographic__demographic_id	563fcdc3-c1e9-5e97-9910-a3a447746859
gdc__demographic__ethnicity	not hispanic or latino
gdc__demographic__gender	male
gdc__demographic__race	white
gdc__demographic__year_of_birth	1943
gdc__demographic__year_of_death	2010
gdc__diagnoses__age_at_diagnosis	23587
gdc__diagnoses__classification_of_tumor	not reported
gdc__diagnoses__days_to_birth	-23587.0
gdc__diagnoses__days_to_death	1271.0
gdc__diagnoses__diagnosis_id	666b8bc5-82f1-509e-947f-ae1a0af6a7c1
gdc__diagnoses__last_known_disease_status	not reported
gdc__diagnoses__morphology	8170/3
gdc__diagnoses__primary_diagnosis	Hepatocellular carcinoma NOS
gdc__diagnoses__prior_malignancy	not reported
gdc__diagnoses__progression_or_recurrence	not reported
gdc__diagnoses__site_of_resection_or_biopsy	Liver
gdc__diagnoses__tissue_or_organ_of_origin	Liver
gdc__diagnoses__tumor_grade	not reported
gdc__diagnoses__tumor_stage	stage i
gdc__diagnoses__vital_status	dead
gdc__disease_type	Adenomas and Adenocarcinomas
gdc__experimental_strategy	miRNA-Seq
gdc__exposures__bmi	41.96353097451998
gdc__exposures__exposure_id	7a5eaa5a-6daf-52cb-8639-d53e8663f7b0
gdc__exposures__height	182.0
gdc__exposures__weight	139.0
gdc__file_id	548c1310-b3b7-4bca-866e-8a242a2e9ab0
gdc__file_name	5fad541b-0a85-4569-a998-0c85783d2b6d.mirbase21.mirnas.quantification.txt
gdc__file_size	50351
gdc__input_files__data_category	Raw Sequencing Data
gdc__input_files__data_format	BAM
gdc__input_files__data_type	Aligned Reads
gdc__input_files__experimental_strategy	miRNA-Seq
gdc__input_files__platform	Illumina
gdc__md5sum	0041e2305f20a20e96f9f1648642e194
gdc__portions__is_ffpe	false
gdc__portions__portion_id	42346ddb-34ec-449b-a88b-954127cf68b4
gdc__portions__portion_number	11
gdc__portions__weight	30.0
gdc__primary_site	Liver and intrahepatic bile ducts
gdc__program__dbgap_accession_number	phs000178
gdc__program__name	TCGA
gdc__program__program_id	b80aa962-9650-5110-b3eb-bd087da808db
gdc__project__disease_type	Liver Hepatocellular Carcinoma
gdc__project__primary_site	Liver
gdc__project__project_id	TCGA-LIHC
gdc__project__releasable	false
gdc__project__released	true
gdc__samples__days_to_collection	2375
gdc__samples__initial_weight	80.0
gdc__samples__oct_embedded	true
gdc__samples__pathology_report_uuid	5846FA3D-E3AD-4530-8A5F-5D90CD17F539
gdc__samples__sample_id	5243430a-7662-4858-85ed-a0c95fd1ecdd
gdc__samples__sample_type	Primary Tumor
gdc__samples__sample_type_id	01
gdc__slides__percent_lymphocyte_infiltration	0.0
gdc__slides__percent_monocyte_infiltration	0.0
gdc__slides__percent_necrosis	0.0
gdc__slides__percent_neutrophil_infiltration	0.0
gdc__slides__percent_normal_cells	0.0
gdc__slides__percent_stromal_cells	0.0
gdc__slides__percent_tumor_cells	100.0
gdc__slides__percent_tumor_nuclei	95.0
gdc__slides__section_location	TOP
gdc__slides__slide_id	7340122f-591c-4f08-ae11-a6b34863f42f
gdc__submitter_id	mirna_swap_dr11_160_MirnaExpression7dace69c-0267-4a2c-a703-60de4124ea82_profiling
gdc__tissue_source_site__bcr_id	NCH
gdc__tissue_source_site__code	2Y
gdc__tissue_source_site__name	Moffitt Cancer Center
gdc__tissue_source_site__tissue_source_site_id	33e340f9-a97a-56eb-a3e6-aad831681cb4
gdc__treatments__treatment_id	3b993486-e97c-5dc4-8a73-e2d2f788a8ea
gdc__type	mirna_expression
gdc__updated_datetime	2018-09-08T13:43:34.032262+00:00
manually_curated__data_format	BED
manually_curated__download_date	2018-11-06T09:09:24.513+01:00
manually_curated__exp_data_bed_url	ftp://bioinformatics.iasi.cnr.it/opengdc/bed/tcga/tcga-lihc/mirna_expression_quantification/764e0717-d590-4e52-96ca-96e5ba7673f7-meq.bed
manually_curated__exp_metadata_url	ftp://bioinformatics.iasi.cnr.it/opengdc/bed/tcga/tcga-lihc/mirna_expression_quantification/764e0717-d590-4e52-96ca-96e5ba7673f7-meq.bed.meta
manually_curated__genome_built	GRCh38
manually_curated__local_file_size	129722
manually_curated__local_md5	6c1f01bccc03accf21f43df9640907c1
manually_curated__opengdc_download_date	2018-10-16T17:10:56.000588+02:00
manually_curated__opengdc_file_md5	d5c23dce8ec446ae5c0c1a3c206e8cee
manually_curated__opengdc_file_size	50350
manually_curated__opengdc_id	764e0717-d590-4e52-96ca-96e5ba7673f7-meq
manually_curated__origin_file_size	129722
manually_curated__origin_last_modified_date	Tue Oct 16 17:37:00 CEST 2018
manually_curated__origin_md5	6c1f01bccc03accf21f43df9640907c1
manually_curated__tissue_status	tumoral
